Inventor
SHAO LIXIN
US34 patents
⚠️ This page may combine multiple inventors who share the name “SHAO LIXIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
31 patentsUS9334274B2May 10, 2016
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
INCYTE CORP57 citations97
US10640506B2May 5, 2020
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors
INCYTE CORP19 citations94
US10442803B2Oct 15, 2019
Tricyclic heterocycles as bet protein inhibitors
INCYTE CORP17 citations94
US10138248B2Nov 27, 2018
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors
INCYTE CORP36 citations94
US9777003B2Oct 3, 2017
Tricyclic heterocycles as bet protein inhibitors
INCYTE CORP25 citations94
US9309246B2Apr 12, 2016
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP33 citations94
US9193733B2Nov 24, 2015
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
INCYTE CORP33 citations94
US10065963B2Sep 4, 2018
Heterocyclic compounds as PI3K-γ inhibitors
INCYTE CORP16 citations92
US11091484B2Aug 17, 2021
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP8 citations84
US10975088B2Apr 13, 2021
Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
INCYTE CORP6 citations84
US10738057B2Aug 11, 2020
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP5 citations84
US10479795B2Nov 19, 2019
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors
INCYTE CORP13 citations84
US10472368B2Nov 12, 2019
Heterocyclic compounds as PI3K-γ inhibitors
INCYTE CORP12 citations84
US11926630B2Mar 12, 2024
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP2 citations73
US11926616B2Mar 12, 2024
Aminopyrazine diol compounds as PI3K-γ inhibitors
INCYTE CORP2 citations73
US11352340B2Jun 7, 2022
Pyridine and pyridimine compounds as PI3K-gamma inhibitors
INCYTE CORP3 citations73
US11225486B2Jan 18, 2022
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP4 citations73
US11091491B2Aug 17, 2021
Heterocyclic compounds as PI3K-y inhibitors
INCYTE CORP4 citations73
US10669262B2Jun 2, 2020
Aminopyrazine diol compounds as PI3K-γ inhibitors
INCYTE CORP4 citations73
US11078204B2Aug 3, 2021
Heterocyclic derivatives as PI3K inhibitors
INCYTE CORP2 citations72
US11046658B2Jun 29, 2021
Aminopyrazine derivatives as PI3K-γ inhibitors
INCYTE CORP4 citations72
US11691971B2Jul 4, 2023
Naphthyridinone compounds as JAK2 V617F inhibitors
INCYTE CORP1 citations63
US12516065B2Jan 6, 2026
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP0 citations62
US12421197B2Sep 23, 2025
Aminopyrazine derivatives as PI3K-γ inhibitors
INCYTE CORP0 citations62
US12365668B2Jul 22, 2025
Aminopyrazine diol compounds as PI3K-y inhibitors
INCYTE CORP0 citations62
US12030885B2Jul 9, 2024
Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors
INCYTE CORP0 citations62
US12006320B2Jun 11, 2024
Heterocyclic derivatives as PI3K inhibitors
INCYTE CORP0 citations62
US11952367B2Apr 9, 2024
Pyridine and pyridimine compounds as PI3K-gamma inhibitors
INCYTE CORP0 citations62
US11773102B2Oct 3, 2023
Heterocyclic compounds as PI3K-γ inhibitors
INCYTE CORP0 citations62
US11958861B2Apr 16, 2024
Spirocyclic lactams as JAK2 V617F inhibitors
INCYTE CORP1 citations60
US11306079B2Apr 19, 2022
3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitors
INCYTE CORP0 citations51
RODGERS JAMES D
2 patentsUS8933085B2Jan 13, 2015
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
RODGERS JAMES D96 citations98
US8716303B2May 6, 2014
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
RODGERS JAMES D109 citations97